# Shortness of Breath/Hypoxia â€“ RRT Protocol with Virtua Voorhees Addenda

**Guideline Used:**  
British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) 2019 British Guideline on the Management of Asthma, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Report, American Thoracic Society/European Respiratory Society (ATS/ERS) 2017 Clinical Practice Guidelines for Acute Respiratory Failure  
**Official Sources:**  
https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/  
https://goldcopd.org/2023-gold-report-2/  
https://www.atsjournals.org/doi/10.1164/rccm.201610-2058ST

## CARD INTERFACE LAYOUT

### Card 0 â€“ Dynamic Action Card (Node Dependent)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ RESPIRATORY DISTRESS RRT                                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â±ï¸ TIME OF ONSET: 2 hours ago                              â”‚
â”‚ Progression: Acute over 2 hours                            â”‚
â”‚                                                           â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                        â”‚
â”‚ â”‚     IMMEDIATE ACTIONS           â”‚                        â”‚
â”‚ â”‚ â˜‘ High-flow O2 initiated        â”‚ [15L NRB mask]         â”‚
â”‚ â”‚ â˜‘ Continuous SpO2 monitoring    â”‚ [Connected]            â”‚
â”‚ â”‚ â˜‘ ABG ordered STAT             â”‚ [Drawn, pending]       â”‚
â”‚ â”‚ â˜‘ Portable CXR ordered         â”‚ [Completed]            â”‚
â”‚ â”‚ â˜ BiPAP at bedside             â”‚ [Setup in progress]    â”‚
â”‚ â”‚ â˜ Intubation kit available     â”‚ [RSI Protocol ready]   â”‚
â”‚ â”‚ â˜ RT notified for assessment   â”‚ [Called]               â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ Work of Breathing: Severe       â”‚                        â”‚
â”‚ â”‚ Accessory muscles: Yes          â”‚                        â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                        â”‚
â”‚                                                           â”‚
â”‚ VITALS: RR 32, SpO2 86%â†’89%, HR 118, BP 148/92, T 37.8Â°C  â”‚
â”‚                                                           â”‚
â”‚ QUICK ASSESSMENT:                                          â”‚
â”‚ â˜ Speaking full sentences  â˜‘ Tripod positioning           â”‚
â”‚ â˜ Central cyanosis  â˜‘ Accessory muscle use                â”‚
â”‚                                                           â”‚
â”‚ ğŸš¨ CRITICAL SIGNS: RR >30, SpO2 <90% on high flow         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Card 1 â€“ Static Assessment/Differential

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ CAUSES OF SHORTNESS OF BREATH                               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ« RESPIRATORY CAUSES:                                      â”‚
â”‚ â€¢ Obstructive: Severe asthma, COPD exacerbation, pneumothoraxâ”‚
â”‚ â€¢ Restrictive: Pulmonary edema, ARDS, pleural effusion     â”‚
â”‚ â€¢ Vascular: Pulmonary embolism, pulmonary hypertension     â”‚
â”‚                                                           â”‚
â”‚ ğŸ’“ CARDIAC CAUSES:                                          â”‚
â”‚ â€¢ Pump failure: Acute heart failure, cardiogenic shock, MI â”‚
â”‚ â€¢ Rhythm: A-fib with RVR, other tachyarrhythmias          â”‚
â”‚                                                           â”‚
â”‚ ğŸ©¸ OTHER CAUSES:                                            â”‚
â”‚ â€¢ Hematologic: Severe anemia, CO poisoning                 â”‚
â”‚ â€¢ Metabolic: DKA, metabolic acidosis, sepsis              â”‚
â”‚ â€¢ Neurologic: Guillain-BarrÃ©, myasthenia gravis           â”‚
â”‚ â€¢ Psychological: Anxiety, hyperventilation syndrome        â”‚
â”‚                                                           â”‚
â”‚ RED FLAGS:                                                 â”‚
â”‚ â€¢ Sudden onset + chest pain (PE, pneumothorax)            â”‚
â”‚ â€¢ Orthopnea + leg swelling (heart failure)                â”‚
â”‚ â€¢ Fever + productive cough (pneumonia)                     â”‚
â”‚ â€¢ Recent travel/surgery (PE risk)                          â”‚
â”‚                                                           â”‚
â”‚ CRITICAL HISTORY: Onset (sudden vs gradual), triggers,     â”‚
â”‚ associated symptoms, previous episodes, current medications â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Card 2 â€“ Static Physical Exam/Medications

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHYSICAL EXAM & MEDICATIONS                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ FOCUSED EXAM:                                              â”‚
â”‚ â€¢ Vitals: RR >20, SpO2 <95%, assess accessory muscle use   â”‚
â”‚ â€¢ General: Position, cyanosis, mental status               â”‚
â”‚ â€¢ Pulmonary: Wheeze (obstruction), rales (edema), absent   â”‚
â”‚ â€¢ Cardiac: S3/S4, murmurs, JVD assessment                 â”‚
â”‚ â€¢ Extremities: Edema, cyanosis, unilateral swelling       â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š OXYGEN THERAPY:                                          â”‚
â”‚ Target SpO2: 88-92% (COPD), >92% (non-COPD)               â”‚
â”‚ NC 1-6L â†’ Simple mask 5-10L â†’ NRB 15L â†’ BiPAP             â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š BRONCHODILATORS:                                         â”‚
â”‚ â€¢ Albuterol 2.5-5mg neb q20min x3 or continuous           â”‚
â”‚ â€¢ Ipratropium 0.5mg neb q6h with albuterol                â”‚
â”‚ â€¢ Magnesium 2g IV over 20min (severe asthma)              â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š CORTICOSTEROIDS:                                         â”‚
â”‚ â€¢ Prednisone 40-80mg daily x5 days (asthma/COPD)          â”‚
â”‚ â€¢ Methylprednisolone 125mg IV q6h (severe cases)          â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š HEART FAILURE:                                           â”‚
â”‚ â€¢ Furosemide 40mg IV (or double home dose)                â”‚
â”‚ â€¢ Nitroglycerin 0.4mg SL q5min or IV 10-20mcg/min         â”‚
â”‚                                                           â”‚
â”‚ BiPAP SETTINGS: IPAP 14-25, EPAP 4-8 (COPD)               â”‚
â”‚ Higher EPAP 8-15 for heart failure                        â”‚
â”‚                                                           â”‚
â”‚ LINK TO RSI PROTOCOL: If BiPAP fails or contraindicated    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## FLOWCHART (Bottom Panel â€“ Mermaid Algorithm)

```mermaid
graph TD
    A[Assess ABCs & Oxygen if SpO2 <90%]
    B[Obtain Focused History & Physical Exam]
    C{Primary Etiology?}
    D[Heart Failure Suspected]
    E[Respiratory Cause]
    F[Combined Etiology]
    G[CXR BNP/NT-proBNP & Echo if available]
    H[CXR ABG & Consider CT-PA]
    I[Comprehensive Workup & Treat Most Likely]
    J{Flash Pulmonary Edema?}
    K[BiPAP/CPAP & High-dose Diuretics]
    L[Standard Diuretics Nitrates ACE-I]
    M{Type of Respiratory Failure?}
    N[Oxygen & Treat Underlying Cause]
    O[BiPAP & Bronchodilators]
    P{Improvement?}
    Q[Continue Treatment & Monitor Closely]
    R[Consider Intubation & ICU Transfer]
    S[Treat Dominant Component First]
    T[Disposition: Home Ward or ICU]
    U[Mechanical Ventilation & ICU Management]

    A --> B
    B --> C
    C -- Cardiac --> D
    C -- Pulmonary --> E
    C -- Mixed --> F
    D --> G
    E --> H
    F --> I
    G --> J
    H --> M
    I --> S
    J -- Yes --> K
    J -- No --> L
    M -- "Type I" --> N
    M -- "Type II" --> O
    K --> P
    L --> P
    N --> P
    O --> P
    P -- Yes --> Q
    P -- No --> R
    S --> P
    Q --> T
    R --> U
```

## NODE-TO-DYNAMIC CARD PROMPT MAPPING (WITH INTERACTIVES)

| **Step (Node)**                    | **Dynamic Card Prompt/Question**                                                                 | **Interactive Components**                                        |
|-------------------------------------|--------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|
| Initial ABC Assessment              | "Patient in respiratory distress. Assess ABCs and initiate oxygen if SpO2 <90%?"               | [ABC Checklist], [O2 Delivery], [SpO2 Monitor], [Vital Signs]     |
| History and Physical Exam           | "Complete focused history and physical examination to identify primary etiology?"               | [History Checklist], [Physical Exam], [Symptom Timeline]           |
| Primary Etiology Determination      | "Based on clinical presentation, what is the most likely primary etiology?"                    | [Cardiac vs Pulmonary], [Mixed Etiology], [Differential Tool]      |
| Heart Failure Evaluation            | "Heart failure suspected. Order CXR, BNP/NT-proBNP, and echo if available?"                   | [Imaging Orders], [Lab Orders], [BNP Interpretation]               |
| Respiratory Cause Workup            | "Respiratory etiology suspected. Order CXR, ABG, and consider CT-PA for PE?"                  | [CXR Review], [ABG Orders], [PE Risk Assessment], [CT-PA Decision] |
| Combined Etiology Assessment        | "Mixed cardiac and pulmonary presentation. Begin comprehensive workup?"                        | [Comprehensive Orders], [Priority Assessment], [Treat Dominant]    |
| Flash Pulmonary Edema Decision      | "Acute cardiogenic pulmonary edema present. Initiate BiPAP/CPAP and high-dose diuretics?"     | [BiPAP Setup], [Diuretic Dosing], [Preload Reduction]             |
| Standard Heart Failure Treatment    | "Standard heart failure management. Begin diuretics, nitrates, and ACE inhibitor?"            | [Furosemide Dosing], [Nitrate Options], [ACE-I Selection]         |
| Respiratory Failure Type Assessment | "Determine type of respiratory failure based on ABG and clinical presentation?"                | [ABG Interpreter], [Type I vs II], [Treatment Selection]          |
| Type I Respiratory Failure          | "Type I (hypoxemic) respiratory failure. Optimize oxygenation and treat cause?"               | [O2 Escalation], [Underlying Cause], [PEEP Consideration]         |
| Type II Respiratory Failure         | "Type II (hypercapnic) respiratory failure. Initiate BiPAP and bronchodilators?"             | [BiPAP Settings], [Bronchodilator Protocol], [Ventilation Support]|
| Treatment Response Assessment       | "Evaluate patient response to initial interventions. Improvement noted?"                       | [Response Checklist], [Vital Trends], [ABG Follow-up]             |
| Continued Treatment                 | "Patient improving with current therapy. Continue treatment and close monitoring?"             | [Treatment Continuation], [Monitoring Schedule], [Reassessment]    |
| Escalation to Intubation           | "Inadequate response to non-invasive therapy. Consider intubation and ICU transfer?"          | [RSI Protocol Link], [Intubation Criteria], [ICU Coordination]    |
| Disposition Planning                | "Patient stable for disposition. Determine appropriate level of care?"                         | [Discharge Criteria], [Ward Admission], [ICU Transfer]            |

**Interactive Highlights:**  
- ABG interpreter: real-time acid-base analysis with oxygenation assessment
- BiPAP optimizer: settings adjustment based on patient response and comfort
- Oxygen escalation guide: stepwise approach with expected SpO2 improvements
- Respiratory failure type calculator: automated classification with treatment recommendations
- Integration with RSI protocol: seamless transition for failed non-invasive ventilation

## INTERACTIVE ELEMENTS

### ABG Interpreter
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚         ABG INTERPRETATION              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ pH: [7.28]     (7.35-7.45)             â”‚
â”‚ PaCO2: [58]    (35-45 mmHg)            â”‚
â”‚ PaO2: [65]     (80-100 mmHg)           â”‚
â”‚ HCO3: [26]     (22-28 mEq/L)           â”‚
â”‚ SaO2: [89]%    (>95%)                  â”‚
â”‚                                         â”‚
â”‚ PRIMARY DISORDER:                       â”‚
â”‚ ğŸ”´ Respiratory Acidosis                 â”‚
â”‚                                         â”‚
â”‚ COMPENSATION:                           â”‚
â”‚ Partial metabolic compensation          â”‚
â”‚                                         â”‚
â”‚ OXYGENATION:                           â”‚
â”‚ Hypoxemia - moderate                    â”‚
â”‚                                         â”‚
â”‚ A-a Gradient: 32 (elevated)            â”‚
â”‚ P/F Ratio: 130 (moderate ARDS)         â”‚
â”‚                                         â”‚
â”‚ INTERPRETATION: Type II Respiratory     â”‚
â”‚ Failure with moderate hypoxemia         â”‚
â”‚                                         â”‚
â”‚ [CALCULATE] [TREND] [TREATMENT GUIDE]   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### BiPAP Optimization Tool
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      BiPAP SETTINGS OPTIMIZER           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Current Settings:                       â”‚
â”‚ IPAP: 15 cmH2O [â–²â–¼]                    â”‚
â”‚ EPAP: 8 cmH2O  [â–²â–¼]                    â”‚
â”‚ Pressure Support: 7 cmH2O               â”‚
â”‚ FiO2: 50%      [â–²â–¼]                    â”‚
â”‚ Backup Rate: 14/min                     â”‚
â”‚                                         â”‚
â”‚ Patient Response (30 min):              â”‚
â”‚ â€¢ RR: 32 â†’ 24 âœ“ Improving               â”‚
â”‚ â€¢ SpO2: 86% â†’ 91% âœ“ Better              â”‚
â”‚ â€¢ pH: 7.28 â†’ 7.32 â†‘ Trending up        â”‚
â”‚ â€¢ PaCO2: 58 â†’ 52 â†“ Improving            â”‚
â”‚                                         â”‚
â”‚ RECOMMENDATIONS:                        â”‚
â”‚ â†‘ Consider IPAP 17 for better PS        â”‚
â”‚ âœ“ EPAP adequate for oxygenation        â”‚
â”‚ â†“ Wean FiO2 to 40% if SpO2 stable      â”‚
â”‚                                         â”‚
â”‚ Comfort Score: 7/10 (Good tolerance)    â”‚
â”‚                                         â”‚
â”‚ [APPLY CHANGES] [REASSESS] [WEAN TRIAL] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Oxygen Escalation Guide
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    OXYGEN DELIVERY ESCALATION           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Current: 15L NRB â†’ SpO2 89%             â”‚
â”‚ Target: SpO2 >92% (or 88-92% if COPD)   â”‚
â”‚                                         â”‚
â”‚ ESCALATION PATHWAY:                     â”‚
â”‚                                         â”‚
â”‚ 1. âœ“ Non-Rebreather 15L (Current)       â”‚
â”‚    FiO2: ~85-90%                        â”‚
â”‚                                         â”‚
â”‚ 2. High-Flow Nasal Cannula              â”‚
â”‚    Flow: 40-60L, FiO2: 60-80%          â”‚
â”‚    Expected SpO2: 92-95%                â”‚
â”‚    [SETUP HFNC]                         â”‚
â”‚                                         â”‚
â”‚ 3. BiPAP/CPAP (Current plan)            â”‚
â”‚    PEEP effect + ventilatory support    â”‚
â”‚    Expected SpO2: >92%                  â”‚
â”‚    [BiPAP READY]                        â”‚
â”‚                                         â”‚
â”‚ 4. âš ï¸ Mechanical Ventilation             â”‚
â”‚    If BiPAP fails or contraindicated    â”‚
â”‚    [LINK TO RSI PROTOCOL]               â”‚
â”‚                                         â”‚
â”‚ Time to next escalation: 30 minutes     â”‚
â”‚ [CALCULATE FiO2] [SET TIMER]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## VIRTUA VOORHEES RESPIRATORY DISTRESS ADDENDA

- **Respiratory Therapy Integration:** 24/7 RT coverage with BiPAP/CPAP expertise and high-flow nasal cannula capabilities
- **RSI Protocol Integration:** Seamless transition to rapid sequence intubation protocol when non-invasive ventilation fails
- **ICU Coordination:** Direct communication with critical care team for mechanical ventilation and advanced respiratory support
- **Quality Metrics:** Time to BiPAP initiation, non-invasive ventilation success rates, intubation avoidance rates

## REFERENCE (GUIDELINE & SOURCE)
British Thoracic Society/Scottish Intercollegiate Guidelines Network. 2019 British Guideline on the Management of Asthma.  
https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/

**Additional References:**  
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Report  
https://goldcopd.org/2023-gold-report-2/

American Thoracic Society/European Respiratory Society Clinical Practice Guidelines for Acute Respiratory Failure 2017  
https://www.atsjournals.org/doi/10.1164/rccm.201610-2058ST

**All steps follow current evidence-based guidelines for acute respiratory failure management with integrated non-invasive ventilation protocols and optimized for early recognition of patients requiring escalation to mechanical ventilation via RSI protocol.**
